Sex-Dependent Effects of the APOE ɛ4 Allele on Behavioral Traits and White Matter Structures in Young Adults.


Journal

Cerebral cortex (New York, N.Y. : 1991)
ISSN: 1460-2199
Titre abrégé: Cereb Cortex
Pays: United States
ID NLM: 9110718

Informations de publication

Date de publication:
01 01 2021
Historique:
received: 19 11 2019
revised: 08 08 2020
accepted: 09 08 2020
pubmed: 22 9 2020
medline: 11 1 2022
entrez: 21 9 2020
Statut: ppublish

Résumé

The APOE ɛ4 allele is associated with a risk of Alzheimer's disease in the elderly, with the association being pronounced in females. Conversely, findings of the effects of the APOE ɛ4 allele in young adults are mixed. Here, we investigated the sex-genotype interaction effects of the APOE ɛ4 allele on cognitive functions as well as brain structures among 1258 young adults. After adjusting for multiple comparisons, there were significant effects of the interaction between sex and the number of APOE ɛ4 allele on some speed tasks (e.g., simple processing speed tasks and the reverse Stroop task) as well as on regional white matter volume (rWMV). The observed sex-genotype interaction conferred better cognitive performance and greater rWMV in the anterior frontal and precentral white matter areas in females having more APOE ɛ4 alleles and reduced rWMV in the same areas in male having more APOE ɛ4 alleles. These findings support the long-debated antagonistic pleiotropic effects of the APOE ɛ4 allele in females.

Identifiants

pubmed: 32954402
pii: 5909022
doi: 10.1093/cercor/bhaa251
pmc: PMC7727389
doi:

Substances chimiques

ApoE protein, human 0
Apolipoprotein E4 0
Apolipoproteins E 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

672-680

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press.

Références

J Hypertens. 2002 Oct;20(10):2017-21
pubmed: 12359980
Ann Neurol. 2014 Apr;75(4):563-73
pubmed: 24623176
Neuroimage. 2009 Jan 1;44(1):83-98
pubmed: 18501637
Cereb Cortex. 2019 Jul 22;29(8):3211-3219
pubmed: 30124797
PLoS One. 2014 Mar 25;9(3):e93104
pubmed: 24667298
Nat Rev Neurosci. 2003 Oct;4(10):829-39
pubmed: 14523382
PLoS One. 2015 Sep 23;10(9):e0136386
pubmed: 26397946
Hum Brain Mapp. 2014 Aug;35(8):3646-60
pubmed: 24343872
Cortex. 2013 Sep;49(8):2106-25
pubmed: 23079491
Neurology. 2000 May 23;54(10):1949-54
pubmed: 10822435
Neuropsychologia. 1971 Mar;9(1):97-113
pubmed: 5146491
Neurobiol Aging. 2012 Apr;33(4):720-731.e4
pubmed: 20619505
PLoS One. 2012;7(11):e48895
pubmed: 23152815
Front Hum Neurosci. 2019 Jan 18;12:543
pubmed: 30713493
Nat Rev Neurosci. 2013 May;14(5):365-76
pubmed: 23571845
Neuroimage. 2000 Jun;11(6 Pt 1):805-21
pubmed: 10860804
Lancet Neurol. 2007 Jun;6(6):494-500
pubmed: 17509484
J Biol Chem. 1985 May 25;260(10):6240-7
pubmed: 3922972
Dement Geriatr Cogn Disord. 2007;24(5):348-62
pubmed: 17911980
JAMA Neurol. 2017 Oct 1;74(10):1178-1189
pubmed: 28846757
Nat Rev Neurol. 2013 Feb;9(2):106-18
pubmed: 23296339
Sci Rep. 2018 Feb 27;8(1):3694
pubmed: 29487315
Neurosci Biobehav Rev. 2018 Nov;94:49-58
pubmed: 30125600
J Biol Chem. 1997 Dec 26;272(52):33360-6
pubmed: 9407129
J Neurosci. 1998 May 1;18(9):3180-5
pubmed: 9547226
Oncotarget. 2015 Sep 29;6(29):26663-74
pubmed: 26397226
Exp Brain Res. 1984;55(1):187-91
pubmed: 6745350
Neuroimage. 2015 Apr 15;110:124-35
pubmed: 25659462
Neurology. 2006 Jan 10;66(1):35-40
pubmed: 16401842
J Clin Invest. 1989 Mar;83(3):1015-31
pubmed: 2493483
Pediatr Res. 2010 Mar;67(3):293-9
pubmed: 19952867
Trends Cogn Sci. 2000 Oct 1;4(10):383-391
pubmed: 11025281
Neuroimage. 2010 Jun;51(2):578-85
pubmed: 20226253
Neurodegener Dis Manag. 2015;5(1):37-48
pubmed: 25711453
Neuroimage. 2013 Aug 15;77:222-36
pubmed: 23578577
J Alzheimers Dis. 2014;40(1):37-43
pubmed: 24326516
Neuroimage. 2011 Mar 15;55(2):681-7
pubmed: 21111830
Nature. 2018 Oct;562(7726):210-216
pubmed: 30305740
Cereb Cortex. 2008 Jan;18(1):46-52
pubmed: 17412719
Alzheimers Dement. 2008 Jul;4(4):251-4
pubmed: 18631975
Brain Imaging Behav. 2020 Jun;14(3):806-820
pubmed: 30617785
Mol Psychiatry. 2011 Sep;16(9):908-16
pubmed: 20820167

Auteurs

Hikaru Takeuchi (H)

Division of Developmental Cognitive Neuroscience, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan.

Hiroaki Tomita (H)

Department of Psychiatry, Graduate School of Medicine, Tohoku University, Sendai 980-8575, Japan.
Department of Disaster Psychiatry, International Research Institute of Disaster Science, Tohoku University, Sendai 980-8575, Japan.

Ryan Browne (R)

Department of Advanced Brain Science, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan.

Yasuyuki Taki (Y)

Division of Medical Neuroimaging Analysis, Department of Community Medical Supports, Tohoku Medical Megabank Organization, Tohoku University, Sendai 980-8575, Japan.
Department of Radiology and Nuclear Medicine, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan.

Yoshie Kikuchi (Y)

Department of Disaster Psychiatry, International Research Institute of Disaster Science, Tohoku University, Sendai 980-8575, Japan.

Chiaki Ono (C)

Department of Disaster Psychiatry, International Research Institute of Disaster Science, Tohoku University, Sendai 980-8575, Japan.

Zhiqian Yu (Z)

Department of Disaster Psychiatry, International Research Institute of Disaster Science, Tohoku University, Sendai 980-8575, Japan.

Rui Nouchi (R)

Department of Advanced Brain Science, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan.
Department of Cognitive Health Science, IDAC, Tohoku University, Sendai 980-8575, Japan.
Smart Aging Research Center, Tohoku University, Sendai 980-8575, Japan.

Ryoichi Yokoyama (R)

School of Medicine, Kobe University, Kobe 650-0017, Japan.

Yuka Kotozaki (Y)

Division of Clinical research, Medical-Industry Translational Research Center, Fukushima Medical University School of Medicine, Fukushima 960-1925, Japan.

Seishu Nakagawa (S)

Department of Human Brain Science, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan.
Division of Psychiatry, Tohoku Medical and Pharmaceutical University, Sendai 983-8536, Japan.

Atsushi Sekiguchi (A)

Division of Medical Neuroimaging Analysis, Department of Community Medical Supports, Tohoku Medical Megabank Organization, Tohoku University, Sendai 980-8575, Japan.
Department of Behavioral Medicine, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo 187-8553, Japan.

Kunio Iizuka (K)

Department of Psychiatry, Graduate School of Medicine, Tohoku University, Sendai 980-8575, Japan.

Sugiko Hanawa (S)

Department of Human Brain Science, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan.

Tsuyoshi Araki (T)

ADVANTAGE Risk Management Co., Ltd. , Tokyo 153-0051, Japan.

Carlos Makoto Miyauchi (CM)

Department of Advanced Brain Science, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan.

Kohei Sakaki (K)

Department of Advanced Brain Science, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan.

Takayuki Nozawa (T)

Research Institute for the Earth Inclusive Sensing, Tokyo Institute of Technology, Tokyo 152-8550, Japan.

Shigeyuki Ikeda (S)

Department of Ubiquitous Sensing, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan.

Susumu Yokota (S)

Division for Experimental Natural Science, Faculty of Arts and Science, Kyushu University, Fukuoka 819-0385, Japan.

Daniele Magistro (D)

Department of Sport Science, School of Science and Technology, Nottingham Trent University, Nottingham NG11 8NS, UK.

Yuko Sassa (Y)

Division of Developmental Cognitive Neuroscience, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan.

Ryuta Kawashima (R)

Division of Developmental Cognitive Neuroscience, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan.
Department of Advanced Brain Science, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan.
Department of Ubiquitous Sensing, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH